| Dr Mark Anthony Gay, MD | |
|
417 W 3rd Ave, Albany, GA 31701-1943 | |
| (229) 317-2207 | |
| (229) 317-2214 |
| Full Name | Dr Mark Anthony Gay |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 27 Years |
| Location | 417 W 3rd Ave, Albany, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417943804 | NPI | - | NPPES |
| P00321252 | Other | GA | RAILROAD MEDICARE |
| 00817209L | Medicaid | GA | |
| 364840 | Other | GA | WELLCARE |
| 52820011-008 | Other | GA | BCBS |
| 00817209M | Medicaid | GA | |
| 52820011-009 | Other | GA | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 046852 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital And Manor | Bainbridge, GA | Hospital |
| Medical Center Barbour | Eufaula, AL | Hospital |
| John D Archbold Memorial Hospital | Thomasville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southland Bainbridge Hospitalist Group, Llc | 7214248335 | 38 |
| Southland Medical Solutions Of Eufaula, Pl | 1951469410 | 4 |
News Archive
"Devastating" and "dismal." That's how leading researchers describe the present outlook for malignant brain tumors. The median survival rate for patients with glioblastoma multiforme, or GBM, is a mere 14.2 months.
Seldom can one say $3.8 million is just the tip of the iceberg, but a newly awarded grant from Gilead Sciences, Inc. is just that. MUSC transplant surgeon Kenneth Chavin, M.D., Ph.D., says the true value of the multi-center drug trial is closer to $26 million, including $22 million in free drugs provided by the pharmaceutical company.
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week's Lancet also indicate that the new "Quad" pill is faster acting, doesn't have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.
Now, a new study by a team of researchers at the Mount Sinai Health System in New York has shown that blood thinners may reduce the risk of death by up to 50 percent among severely ill hospitalized COVID-19 patients.
ABO-incompatible heart transplantation (heart transplantation among non-compatible blood groups) can be safely performed in infants a year old or younger, researchers reported at the American Heart Association's Scientific Sessions 2007.
› Verified 8 days ago
| Entity Name | Southland Bainbridge Hospitalist Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356735336 PECOS PAC ID: 7214248335 Enrollment ID: O20150616002069 |
News Archive
"Devastating" and "dismal." That's how leading researchers describe the present outlook for malignant brain tumors. The median survival rate for patients with glioblastoma multiforme, or GBM, is a mere 14.2 months.
Seldom can one say $3.8 million is just the tip of the iceberg, but a newly awarded grant from Gilead Sciences, Inc. is just that. MUSC transplant surgeon Kenneth Chavin, M.D., Ph.D., says the true value of the multi-center drug trial is closer to $26 million, including $22 million in free drugs provided by the pharmaceutical company.
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week's Lancet also indicate that the new "Quad" pill is faster acting, doesn't have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.
Now, a new study by a team of researchers at the Mount Sinai Health System in New York has shown that blood thinners may reduce the risk of death by up to 50 percent among severely ill hospitalized COVID-19 patients.
ABO-incompatible heart transplantation (heart transplantation among non-compatible blood groups) can be safely performed in infants a year old or younger, researchers reported at the American Heart Association's Scientific Sessions 2007.
› Verified 8 days ago
| Entity Name | Southland Consolidated Emergency Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174917124 PECOS PAC ID: 2860792066 Enrollment ID: O20151119001289 |
News Archive
"Devastating" and "dismal." That's how leading researchers describe the present outlook for malignant brain tumors. The median survival rate for patients with glioblastoma multiforme, or GBM, is a mere 14.2 months.
Seldom can one say $3.8 million is just the tip of the iceberg, but a newly awarded grant from Gilead Sciences, Inc. is just that. MUSC transplant surgeon Kenneth Chavin, M.D., Ph.D., says the true value of the multi-center drug trial is closer to $26 million, including $22 million in free drugs provided by the pharmaceutical company.
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week's Lancet also indicate that the new "Quad" pill is faster acting, doesn't have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.
Now, a new study by a team of researchers at the Mount Sinai Health System in New York has shown that blood thinners may reduce the risk of death by up to 50 percent among severely ill hospitalized COVID-19 patients.
ABO-incompatible heart transplantation (heart transplantation among non-compatible blood groups) can be safely performed in infants a year old or younger, researchers reported at the American Heart Association's Scientific Sessions 2007.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mark Anthony Gay, MD Po Box 408, Albany, GA 31702-0408 Ph: (205) 437-6098 | Dr Mark Anthony Gay, MD 417 W 3rd Ave, Albany, GA 31701-1943 Ph: (229) 317-2207 |
News Archive
"Devastating" and "dismal." That's how leading researchers describe the present outlook for malignant brain tumors. The median survival rate for patients with glioblastoma multiforme, or GBM, is a mere 14.2 months.
Seldom can one say $3.8 million is just the tip of the iceberg, but a newly awarded grant from Gilead Sciences, Inc. is just that. MUSC transplant surgeon Kenneth Chavin, M.D., Ph.D., says the true value of the multi-center drug trial is closer to $26 million, including $22 million in free drugs provided by the pharmaceutical company.
A new once-daily pill combining three antiretrovirals and a booster molecule is a safe and effective alternative to two widely used drug regimens for newly diagnosed HIV-positive adults who have had no previous treatment. The findings of two large international randomised trials published in this week's Lancet also indicate that the new "Quad" pill is faster acting, doesn't have the neuropsychiatric side effects associated with other combinations, and could improve compliance with treatment.
Now, a new study by a team of researchers at the Mount Sinai Health System in New York has shown that blood thinners may reduce the risk of death by up to 50 percent among severely ill hospitalized COVID-19 patients.
ABO-incompatible heart transplantation (heart transplantation among non-compatible blood groups) can be safely performed in infants a year old or younger, researchers reported at the American Heart Association's Scientific Sessions 2007.
› Verified 8 days ago
Dr. Andrew George Misulia, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-317-2207 Fax: 229-317-2214 | |
Gregory Walter, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 2000 Palmyra Rd, Albany, GA 31701 Phone: 229-434-2000 | |
Dr. Elmera V Dejarme, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-317-2207 Fax: 229-317-2214 | |
Dr. Gopala Krishna Derebail, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-317-2207 Fax: 229-317-2214 | |
Dr. Alfred Lee Woodard, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-317-2207 Fax: 229-317-2214 | |
Dr. Christopher Andrew Ham, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-317-2207 Fax: 229-317-2214 | |
Larry Alan Medley, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 417 W 3rd Ave, Albany, GA 31701 Phone: 229-312-1000 |